Studies on antibody response to recombinant Rta protein in patient with nasopharyngeal carcinoma

Chinese Journal of Microbiology and Immunology

Volumn 26, Issue 11, 2006, Pages 1057-1059

  Ren, Jun ^a   Zhang, Xiao Mei ^a   Zhang, Xiao Guang ^a   Li, Hong Xia ^a   Zhou, Ling ^a   Zeng, Yi ^a  

^a Institute for Viral Disease Control and Prevention   (China)

Author keywords

BRLF1 gene; Epstein Barr virus(EBV); Nasopharyngeal carcinoma(NPC)

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CANCER DIAGNOSIS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE MARKER; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC SCREENING; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; SENSITIVITY AND SPECIFICITY;

EID: 33847069659     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chinese source
2. Rikson AB, Kieff E. Epstein-Barr virus, in: Fields BN, Knipe DM, Howley PM, et al. Fields virology, Philadelphia: Lippincott-Raven Publishers. 1996, 2397-2446.
3. Chinese source
4. Zeng Y, Pi GH, Deng H, et al. Epstein-Barr virus seroepidemiology in China. AIDS Res, 1986, 2 (Suppl 1): s7-5.
5. Chinese source
6. Chinese source
7. Feng P, Ren EC, Liu D, et al. Expression of Epstein-Barr virus lytic gene BRLF1. in nasopharyngeal carcinoma: potential use in diagnosis. J GenVirol, 2000, 81(Pt 10):, 2417-2433.
8. Chinese source